Equity Overview
Price & Market Data
Price: $29.04
Daily Change: -$0.63 / 2.17%
Daily Range: $28.09 - $30.65
Market Cap: $363,782,208
Daily Volume: 160,142
Performance Metrics
1 Week: -5.65%
1 Month: -7.81%
3 Months: 61.60%
6 Months: 146.9%
1 Year: 171.4%
YTD: 6.49%
Company Details
Employees: 14
Sector: Health technology
Industry: Biotechnology
Country:
Details
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.